Glenmark Life Sciences (NSE:GLS, BOM:543322) has rebranded to Alivus Life Sciences following its acquisition by Nirma, the company said in a Saturday release filed with the Indian stock exchanges.
The company said its BSE symbol remains unchanged, while the NSE symbol has changed to ALIVUS from GLS effective Jan. 20.
Glenmark Life Sciences share were up 0.2% in recent trading activity.
Price (INR): ₹1086.00, Change: ₹+1.7, Percent Change: +0.15%
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.